Optiver Holding
IDXX icon

Optiver Holding’s Idexx Laboratories IDXX Stock Holding History

Optiver Holding’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48
Closed -$20.2K – 1534
2025
Q1 		$20.2K Buy
+48
New +$20.8K ﹤0.01% 706
2023
Q3 		– Sell
-1
Closed -$502 – 584
2023
Q2 		$502 Buy
+1
New +$479 ﹤0.01% 459
2022
Q2 		– Sell
-107
Closed -$58K – 433
2022
Q1 		$58K Buy
107
+26
+32% +$13.7K ﹤0.01% 279
2021
Q4 		$50K Hold
81
– – ﹤0.01% 426
2021
Q3 		$50K Buy
81
+60
+286% +$40.3K ﹤0.01% 337
2021
Q2 		$13K Buy
+21
New +$11.6K ﹤0.01% 420

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Optiver Holding's IDXX Position: Q2 2025 in Review

Optiver Holding sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 48 shares — an estimated $20.2K sold.

Optiver Holding first reported a position in IDXX in Q2 2021 and held it in 6 quarters. The position peaked at $58K in Q1 2022. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Optiver Holding reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Optiver Holding sold 48 Idexx Laboratories shares in Q2 2025, an estimated $20.2K.
  • Optiver Holding first reported a position in Idexx Laboratories in Q2 2021 and held it in 6 quarters.
  • Optiver Holding's Idexx Laboratories position peaked at $58K in Q1 2022.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Optiver Holding's 13F filing for Q2 2025, filed 14 Aug 2025.